Healthcare Decheng Capital Leads $45M Series C Round In Chinese Biopharmaceutical Firm KeChow Pharma December 13, 2019 — 11:25
Healthcare Chinese VC Firm Decheng Capital Backs $14M Series A Round Of Biotech Start-Up May 16, 2019 — 15:45
Healthcare Decheng Capital Leads $30M Series C Round In China’s Impact Therapeutics August 3, 2018 — 17:26
Healthcare Hillhouse Capital, Decheng Capital Lead $60M Series B Round In US DNA Sequencing Platform Developer Omniome August 2, 2018 — 10:20
